.png){kind=icon}
药物和医疗光伏发育的患者安全咨询
Good drug safety does not happen by accident
Significant demands are placed on PV systems in order to deliver effective products for which we understand the patient safety. All drugs have risks, but in order to be effective, the efficacy of the drug must outweigh the risks. Thus, the understanding of the Benefit:Risk ratio necessitates a broad knowledge of the drug’s safety profile. This is a continual process as drug safety must be understood today, tomorrow and in the future. Presently the complexity of understanding a drug’s safety profile is ever increasing and this adds to the demands of a PV system. Examples of the ever changing PV environment can be seen by new regulations, more complex drug pharmacology, multiple and varied data sources, differences in medical practice globally, new software, education required to properly use drugs, risk management programs, and the large amount of medications now used to treat disease states.
好消息是，通过计划和有组织的光伏系统，可以以持续的方式清楚地理解药物安全性。该药物可以以正确的方式使用，针对合适的患者，并监测药物安全性以确保益处总是超过患者使用该药物的风险。这将我们带来了中心点，良好的药物安全或PV不会发生意外，良好的光伏会支持强大的生命周期管理。必须在适当的是，正确的组织，人才，工具和资源。凭借我们的安全咨询，我们可以提供知识和专业知识，以确保您的光伏系统能够有效监控产品的安全性，或将您目前的光伏系统转化为高度有组织和有效的PV功能。
患者安全咨询服务：
- We have an internal consulting team of experts in安全和风险管理统计学家，数据经理，临床研究专业人员和流程顾问提供支持的光伏运营，他们能够咨询光伏并将其知识和专业知识转化为我们客户的赢得策略和最佳做法
- Examples of consulting services include: PV organizational design, PV planning, PV governance, design of risk management activities including RMPs and REMS, PV systems gap analysis, PV regulatory interaction, PV audits, PV inspection preparation, PV crisis management, and PV training
PV咨询，提高患者安全
我们的目标是推进整个行业的光伏，以便以最有效的方式开发和使用药物。我们的PV咨询致力于与客户合作，并利用我们广泛的资源，专业知识和知识来满足这一目标。